Сравнительный анализ активности лактаптина, полученного в про- и эукариотических системах экспрессии
https://doi.org/10.18699/VJ17.292
Аннотация
Ключевые слова
Об авторах
О. А. КовальРоссия
Новосибирск.
О. Ю. Волкова
Россия
Новосибирск.
А. А. Горчаков
Россия
Новосибирск.
С. В. Кулемзин
Россия
Новосибирск.
А. В. Ткаченко
Россия
Новосибирск.
А. А. Нуштаева
Россия
Новосибирск.
Е. В. Кулигина
Россия
Новосибирск.
В. А. Рихтер
Россия
Новосибирск.
А. В. Таранин
Россия
Новосибирск.
Список литературы
1. Bondarenko D.A., Richter V.A., Kuligina E.V., Koval O.A., Fomin A.S., Skoblov Y.S., Dyachenko I.A., Kravchenko I.N., Sadovnikova E.A., Semushina S.G., Novikova N.I., Turobov V.I., Murashev A.N. Toxicity studies and pharmacokinetics of Lactaptin. Biofarmatsevticheskiy zhurnal = Journal of Biopharmaceuticals. 2015;7(2):4047. (in Russian)
2. Kakarla S., Gottschalk S. CAR T cells for solid tumors: armed and ready to go? Cancer J. 2014; 20(2):151155. DOI 10.1097/PPO.0000000000000032.
3. Kaledin V.I., Nikolin V.P., Galyamova M.R., Vasil’eva E.D., Baymak T.Y., Popova N.A. High apoptosisinducing and antitumor activities of the products of biological but not chemical cyclophosphamide activation. Doklady RAN = Proceedings of the Russian Academy of Sciences. 2002;386(5):705708. (in Russian)
4. Kingston R.E., Chen C.A., Rose J.K. Calcium phosphate transfection. Curr. Protoc. Mol. Biol. 2003;9. DOI 10.1002/0471142727.mb0901s63.
5. Knappskog S., Ravneberg H., Gjerdrum C., Trösse C., Stern B., Pryme I.F. The level of synthesis and secretion of Gaussia princeps luciferase in transfected CHO cells is heavily dependent on the choice of signal peptide. J. Biotechnol. 2007;128(4):705715. DOI 10.1016/j.jbiotec.2006.11.026.
6. Koval O.A., Fomin A.S., Kaledin V.I., Semenov D.V., Potapenko M.O., Kuligina E.V., Nikolin V.P., Nikitenko E.V., Richter V.A. A novel proapoptotic effector lactaptin inhibits tumor growth in mice mo dels. Biochimie. 2012;94(12):24672474. DOI 10.1016/j.biochi.2012.08.017.
7. Koval O., Sakaeva G., Fomin A., Nushtaeva A., Semenov D., Kuligina E., Gulyaeva L., Gerasimov A., Richter V. Sensitivity of endometrial cancer cells from primary human tumour samples to new potential anticancer peptide lactaptin. J. Cancer Res. Ther. 2015;11(2): 345351. DOI 10.4103/09731482.157301.
8. Koval O.A., Tkachenko A.V., Fomin A.S., Semenov D.V., Nushtaeva A.A., Kuligina E.V., Zavjalov E.L., Richter V.A. Lactaptin induces p53independent cell death associated with features of apoptosis and autophagy and delays growth of breast cancer cells in mouse xenografts. PLoS ONE. 2014;9(4):e93921. DOI 10.1371/journal.pone.0093921.
9. Kulemzin S.V., Chikaev N.A., Volkova O.Y., Kuznetsova V.V., Taranin A.V., Gorchakov A.A. Modular lentiviral vector system for chimeric antigen receptor design optimization. Bioorganicheskaya khimiya = Journal of Bioorganic Chemistry. 2017b;43(2):124132. DOI 10.7868/S0132342317020117. (in Russian)
10. Kulemzin S.V., Kuznetsova V.V., Mamonkin M., Taranin A.V., Gorchakov A.A. CAR Тcell therapy: Balance of efficacy and safety. Molekulyarnaya biologiya = Molecular Biology (Moscow). 2017a; 51(2):274287. DOI 10.7868/S0026898417020148. (in Russian)
11. Lo K.M., Sudo Y., Chen J., Li Y., Lan Y., Kong S.M., Chen L., An Q., Gillies S.D. High level expression and secretion of FcX fusion proteins in mammalian cells. Protein Eng. 1998;11(6):495500. DOI 10.1093/protein/11.6.495.
12. Merino D., Lalaoui N., Morizot A., Solary E., Micheau O. TRAIL in cancer therapy: present and future challenges. Expert Opin. Ther. Targets. 2007;11(10):12991314. DOI 10.1517/14728222.11.10.1299.
13. Nagane M., Huang H.J., Cavenee W.K. The potential of TRAIL for cancer chemotherapy. Apoptosis. 2001;6(3):191197. DOI 10.1023/A:1011336726649.
14. Semenov D.V., Fomin A.S., Kuligina E.V., Koval O.A., Matveeva V.A., Babkina I.N., Tikunova N.V., Richter V.A. Recombinant analogs of a novel milk proapoptotic peptide, lactaptin, and their effect on cultured human cells. Protein J. 2010;29(3):174180. DOI 10.1007/s1093001092375.
15. Shagin D.A., Barsova E.V., Yanushevich Y.G., Fradkov A.F., Lukyanov K.A., Labas Y.A., Semenova T.N., Ugalde J.A., Meyers A., Nunez J.M., Widder E.A., Lukyanov S.A., Matz M.V. GFPlike proteins as ubiquitous metazoan superfamily: evolution of functional features and structural complexity. Mol. Biol. Evol. 2004;21(5):841850. DOI 10.1093/molbev/msh079.
16. Song X., Hong S.H., Kwon W.T., Bailey L.M., Basse P., Bartlett D.L., Kwon Y.T., Lee Y.J. Secretory TRAILarmed natural killer cellbased therapy: in vitro and in vivo colorectal peritoneal carcinomatosis xenograft. Mol. Cancer Ther. 2016;15(7):15911601. DOI 10.1158/15357163.MCT150937.